業績

2017年度 :: 学会発表 :: 国際学会 :: 業績

2018 Asian Pacific Association for the Study of the Liver
2018.3. Delhi, India


Suda G, Ogawa K, Sho T, Nakai M, Morikawa K.
Safety and efficacy of paritaprevir/r and ombitasvir comb ination t herapy f or H CV infec ted patien ts with Cryoglobulinemia.

13th Congress of ECCO (European Crohn's and Colitis Organization)
2018.2. Vienna, Austria


Kinoshita K, Takehiko K, Mutsumi N, Satomi O, Reizo Oi, Katsuhiro M, Aki O, Mami S, Kazunori E, Mitsutoshi S, Atsuo M, Toru H, Junji Y, Daiki Mi, Shinji Y, Kota O, Naoya S.
Usefulness of transabdominal ultrasonography in assessing Ulcerative Colitis.

2018 Gastrointestinal Cancers Symposium
2018.1.San Francisco, USA


Muranaka T, Komatsu Y, Yagisawa M, Kawamoto Y, Nakatsumi H, Yuki S, Sakamoto N.
Safety of administration of bevacizumab within a week from placement of a totally implantable central venous port system.

Yuki S, Yamazaki K, Taniguchi H, Sunakawa Y, Kawazoe A, Kagawa Y, Kato K, Hara H, Denda T, Oki E, Moriwaki T, Shiozawa M, Satoh T, Kawakami H, Esaki T, Furuse J, Abe Y, Nomura S, Ohtsu A, Yoshino T.
The nationwide screening project on plasma angiogenesis- related mediators for treatment selection of optimal antiangiogenic inhibitors in metastatic colorectal cancer: GI-SCREEN CRC-Ukit.

Sawada K, Okamoto W, Nakamura Y, Yamanaka T, Yuki S, Yoshino T, Komatsu Y, Sakamoto N, Fujii S.
Survival outcome in HER2 amplified metastatic colorectal cancer (mCRC)

2017 中国消化器内視鏡学術大会(中国内視鏡年会)
2017.11. 北京 , 中華人民共和国

< 招待講演 >
Kato M
Advancement of image-enhanced endoscopy using BLI and LCI in LASEREO system.

ESMO Asia 2017 Congress
2017.11. Singapore, Singapore


Kawamoto Y, Yuki S, Meguro T, Hatanaka K, Uebayashi M, Iwanaga I, Nakamura M, Eto K, Okuda H, Abe M, Oba A, Abe N, Sato A, Nakatsumi H, Muranaka T,Yagisawa M, Oba K, Sakata Y, Sakamoto N, Komatsu Y.
HGCSG 1201: Phase II study of trastuzumab with irinotecan in HER2-positive metastatic or advanced gastric cancer patients previously treated with trastuzumab.

Miyagishima T, Yuki S, Muranaka T, Tsuji Y, Ota Y, Hatanaka K, Okuda H, Sasaki T, Dazai M, Konno J, Nakamura M, Ohta T, Honda T, Ishiguro A, Muto O, Kato S, Sato A, Abe M, Sakata Y, Komatsu Y.
Analysis of tumor location: A retrospective trial for evaluating the safety and efficacy of Regorafenib for patients with metastatic colorectal cancer: HGCSG 1401

Nagashima K, Katsurada T, Otagiri S, Ymanashi K, Kinoshita K, Muranaka T, Hata H, Takeuchi S, Honma R, Gouda T, Mitsuhashi T, Komatsu Y, Sakamoto N.
Two case report of colitis with immune checkpoint inhibitor.

UEGW 2017
2017.10. Barcelona, Spain


Tsuda M, Ohnishi S, Mizushima T, Abiko S, Shimizu Y, Sakamoto N.
Enema of mesenchymal stem cell culture supernatant prevents rectal stricture formation after circumferential endoscopic submucosal dissection in pigs.


Abiko S, Shimizu Y, Mizushima T, Katou M, Matsuda K, Miyamoto S, Tsuda M, Yamamoto K, Ono S, Kudo T, Sakamoto N.
Evaluation of the risk of metachronous squamous cell carcinoma of the oesophagus and the head and neck after endoscopic resection for squamous cell carcinoma of the esophagus based on the genetic polymorphisms of ADH1B and ALDH2.

Kato S, Kuwatani M, Hirata K, Sugiura R,Kawakubo K, Sakamoto N.
The utility of a novel transpapillary dilation technique with a diathermic catheter for severe main pancreatic duct stricture due to chronic pancreatitis.

Matsumoto M
Safety of cold snare colon polypectomy in patients on antihhrombotic medication.

Ono M, Takashi K, Yoshihiko S, Jun I, Taiki K, Kazuteru H, Yoshiya Y, Hirohito N.
The transition of Helicobacter pylori eradication in our institution.

Ono S, Kato M, Matsuda K, Tsuda M, Abiko S, Miyamoto S, Yamamoto K, Kudo T, Shimizu Y, Sakamoto N.
Perioperative management of oral anticoagulants without heparin bridging therapy for patients undergoing endoscopic surgery: A pilot study.

Taya Y.
Connfirmation of the effect of an antagonist to conscious sedation on the prevention of aspiration pneumonia after endoscopic retrograde cholangiopancreatography.

Yoshii S, Mabe K, Ohno M, Matsumoto M, Ono S, Kudo M, Nojima M, Kato M, Sakamoto N.
Diagnostic capability of endoscopy for Helicobacter pylori infection.

AASLD2017
2017.10. Washington D.C., USA


Hige S, Kuno A, Matsuda A, Korenaga M, Tatsumi R, Yamaguchi M, Kimura M, Arakawa T, Nakajima T, Kuwata Y, Ozeki I, Ohmura T, Ishizu H, Toyota J, Mizokami M, Narimatsu H, Karino Y.
Serum Wisteria floribunda agglutinin-positive sialylated Mucin 1 as a meaningful prognostic biomarker after hepatic resection for HCV-positive patients with hepatocellular carcinoma.

Hige S. Karino Y, Ozeki I, Tatsumi R, Yamaguchi M, Kimura M, Arakawa T, Nakajima T, Kuwata Y, Ozeki I, Ohmura T, Toyota J.
Evaluation of Wisteria floribunda agglutinin-positive Mac-2 binding protein glycosylation isomer during the course of antiviral treatment.

2017 International HBV Meeting
2017.9. Washington D.C., USA


Morikawa K, Izumi T, Ando S, Takeda R, Nakamura A, Umemura M, Shimazaki M, Nakai M, Sho T, Suda G, Ogawa K, Sakamoto N.
Hepatitis B virus X protein impairs a host restriction factor via interaction with DDB1 pangenotypically.

APDW 2017
2017.9. Hong Kong


Sano I, Kuwatani M, Sugiura R, Kato S, Kawakubo K, Sakamoto N.
Diagnostic accuracy of endoscopic ultrasonography-guided fine-needle aspiration for gallbladder lesions.


Kuwatani M, Asano T, Hirata K, Sugiura R, Kato S, Kawakubo K, Nakamura T, Hirano S, Sakamoto N.
Changes and lesions in the remnant pancreas after the resection of the 1st IPMN lesion.

ESMO 2017 Congress
2017.9. Madrid, Spain


Komatsu Y, Takashima A, Denda T, Gamoh M, Iwanaga I, Shimodaira H, Nakamura M, Yamaguchi T, Takahashi H, Kobayashi K, Tsuda M, Kobayashi Y, Baba H, Kotake M, Ishioka C, Sato A, Yuki S, Morita S, Takahashi S, Shimada K.
Treatment outcome according to tumor RAS mutation status in TRICOLORE trial : A randomized phase 3 trial of S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment for metastatic colorectal cancer.


Yagisawa M, Nakamura M, Muranaka T, Nakatsumi H, Kawamoto Y, Yuki S, Sasaki T, Meguro T, Dazai M, Ishiguro A, Eto K, Harada K, Kobayashi Y, Miyagishima T, Iwanaga I, Uebayashi M, Hatanaka K, Sakamoto N, Sakata Y, Komatsu Y.
Multicenter prospective cohort study to evaluate of eye disorder induced by chemotherapy including S-1 (EyeDropS study/HGCSG1604).

Yuki S, Komatsu Y, Yagisawa M, Tsuji Y, Harada K, Hatanaka K, Okuda H, Hosokawa A, Ogawa K, Furukawa K, Minami S, Ishiguro A, Honda T, Ohta T, Dazai M, Eto K, Sasaki T, Nakajima J, Sakamoto N, Sakata Y.
A retrospective cohort study evaluating the safety and efficacy of TAS-102 in patients with metastatic colorectal cancer [HGCSG1503] : Updated analysis.

Yuki S, Kato T, Taniguchi H, Hamaguchi T, Akagi K, Denda T, Mizukami T, Oki E, Yamada T, Shiozawa M, Kudo T, Tamura T, Esaki T, Naruge D, Kajiwara T, Nomura S, Fujii S, Shitara K, Ohtsu A, Yoshino T.
The nationwide cancer genome screening project in Japan, SCRUM-Japan GI-SCREEN: Efficient identification of cancer genome alterations in advanced colorectal cancer.

ESMO World Congress on Gastrointestinal Cancer 2017
2017.6. Barcelona, Spain


Dazai M, Yuki S, Nakatsumi H, Tsuji Y, Kobayashi Y, Hatanaka K, Okuda H, Hosokawa A, Furukawa K, Ogawa K, Minami S, Ishiguro A, Honda T, Ohta T, Eto K, Kato T, Nakajima J, Sasaki T, Nakamura M, Shindo Y, Sakata Y, Yoshito Komatsu Y.
First report : A retrospective trial for evaluating the safety and efficacy of TAS-102 for patients with metastatic colorectal cancer : HGCSG1503

Kawamoto Y, Yuki S, Yagisawa M, Muranaka T, Harada K, Nakatsumi H, Kawakubo K, Kuwatani M, Sakamoto N, Komatsu Y.
A retrospective cohort study of the relations between progress of chemotherapy and outcomes for metastatic pancreatic cancer.

Yuki S, Komatsu Y, Muranaka T, Tsuji Y, Harada K, Ota Y, Hatanaka K, Okuda H, Sasaki T, Dazai M, Konno J, Nakamura M, Ohta T, Honda T, Ishiguro A, Muto O, Kato S, Sato A, Abe M, Eto K, Sakamoto N, Sakata Y.
A retrospective cohort study evaluating the safety and efficacy of regorafenib in patients with metastatic colorectal cancer [HGCSG1401] : Analysis of tumor location.

ISSCR2017
2017.6. Boston, USA


Ohnishi S, Mizushima T, Hosono H, Tsuda M, Yamahara K, Sakamoto N.
Oral administration of conditioned medium obtained from amnion-derived mesenchymal stem cell culture prevents esophageal stricture after endoscopic submucosal dissection in pigs.

DDW2017
2017.5. Chicago, USA


Kato S, Kuwatani M, Sugiura R, Sano I, Kawakubo K, Sakamoto N.
The efficacy and safety of a novel transpapillary dilation technique with a diathermic catheter for severe malignant bile duct stricture.

Kawakubo K, Kuwatani M, Kato S, Sano I, Sugiura R, Sakamto N.
Endoscopic reintervention following multiple metallic stent placements for hilar biliary stricture.

Koike Y, Ono Y, Matsuda C, Murai T, Itaya K, Sone T, Yagisawa M, Tsukuda Y, Endo A, Nakamura M, Nagasaka A, Nishikawa S.
A novel method of endoscopic gallbladder stenting: Cutting nasogallbladder tube using a loop cutter.

Ohnishi S, Mizushima T, Shimizu Y, Hatanaka Y, Hatanaka K, Yamamoto K, Homma A, Kuriki Y, Kamiya M, Urano Y, Sakamoto N.
Rapid detection of superficial head and neck squamous cell carcinoma by topically spraying fluorescent probe targeting dipeptidylpeptidase-IV.

Sano I, Katanuma A, Kuwatani M, Kawakami H, Kato H, Itoi T, Ono M, Irisawa A, Okabe Y, Iwashita T, Yasuda I, Ryozawa S, Kaino S, Sakamoto N.
Mid-to long-term outcomes after therapeutic ERCP using balloon-assisted enteroscopy for anastomotic stenosis of choledochojejunostomy or pancreaticojejunostomy: A multicenter observational study in Japan.

The Europian Association for the Study of theLiver (EASL), The International Liver Congress 2017
2017.4. Amsterdam, Netherlands


Kawagishi N.
Prevalence and risk factors of hepatitis B virus reactivation in interferon-free direct-acting antiviral therapies for hepatitis C.

Morikawa K, Shimazaki T, Izumi T, Umemura M, Nakai M, Suda G, Sakamoto N.
Hepatitis B virus infected cell slows down its cell cycle and proliferation by viral protein and replication.

Asian Pacific Association for the Study of the Liver
2017.4. Nagasaki, Japan


Izumi T, Morikawa K, Ando S, Takeda R, Umemura M, Shimazaki T, Kawagishi N, Ohara M, Ito J, Nakai M, Sho T, Suda G, Ogawa K, Sakamoto N.
Hepatitis B virus X protein modulates host restriction factor via interaction with DDB1.

Nakai M, Kawagishi N, Ito J, Sho T, Suda G, Morikawa K, Ogawa K, Sakamoto N.
The change of serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein (M2BPGi) is a predictive marker of the recurrence of hepatocellular carcinoma in patients after RFA.

Umemura M, Morikawa K, Ando S, Takeda R, Izumi T, Shimazaki T, Kawagishi N, Ohara M, Ito J, Nakai M, Sho T, Suda G, Ogawa K, Sakamoto N.
Influence of hepatitis B virus genotypes on innate immune response by impairing mitochondrial antiviral signaling protein.

14th Japan-Korea Joint Symposium on Helicobacter Research
2017.4. Seoul, Korea


Mabe K, Nakamura M, Kato M.
Current status and issues of NHPH infection in Japan.

>